Skip to content
As the United States has long been a life sciences leader, the health of the life sciences sector is a pretty good indicator of […]
Life sciences job report shows growth slowing, but firms still invest in talent Read More »
As antimicrobial resistance (AMR) continues to threaten global public health, its impact on cancer patients is a growing, often overlooked crisis. Patients with cancer
BIO 2025: The urgent need to address AMR and cancer Read More »
We often talk about the exciting jumps in technology and innovation that improve and save lives. What is less frequently discussed is how regulation
BIO 2025: The innovation race vs. the regulatory pace Read More »
Over 7 million Americans live with Alzheimer’s disease, according to the Alzheimer’s Association. For June’s Alzheimer’s Awareness Month, Bio.News sat down with the Alzheimer’s
Alzheimer’s Awareness Month: What to know about a disease impacting millions Read More »
Established in 2012, the Pediatric Priority Review (PPRV) program offers a powerful incentive for companies to develop treatments for rare conditions affecting children. Even
BIO 2025: What is the PRV program and why does it matter? Read More »
The 2025 Biotechnology Innovation Organization (BIO) International Convention highlighted why we – the biotech industry – do what we do. In one word: patients.
BIO 2025: ‘Behind every data point there is a person’ Read More »
The rare disease patient community is the beating heart of the Biotechnology Innovation Organization’s (BIO) mission. Whether it is driving policy that supports innovation,
BIO 2025: Rare disease patients can’t wait Read More »
Food and Drug Administration (FDA) Commissioner Martin A. Makary, M.D., M.P.H., sat down with the Biotechnology Innovation Organization (BIO) President and CEO John F.
BIO 2025: Commissioner Martin Makary, M.D., M.P.H., discusses vision for FDA Read More »
Public health advocates are reevaluating the vaccine landscape, revisiting long-held assumptions about vaccine policy during both public health emergencies and periods of relative calm.
BIO 2025: How do we talk about vaccines now? Read More »
From drug discovery to clinical trials, AI is being used, studied, refined, and advanced as a means to slingshot biotech innovations into the future
BIO 2025: AI Summit highlights role of collaboration in reaching the next frontier Read More »
